Did you know Crohnology has a newsletter? Every few weeks, we send an update on what we’ve been doing, including stories you might have missed. You should sign up. It might save your life.
But probably not. In fact, the FDA gets upset unless we say that our newsletter has not been evaluated by that agency, and it is not intended to diagnose, treat, cure or prevent any disease. So let’s keep our expectations reasonable.
That said, we try to find and write about the most compelling research on Crohn’s disease, ulcerative colitis, and other forms of IBD. We also spotlight new voices in the IBD community online. Sometimes, we run stories that are fun or just funny.
And we hope — really, truly — that the information we find and the stories we post will help you fight the disease. We focus on research you can use, especially cutting-edge drugs or treatments and the most up-to-date knowledge about IBD. We want that information to empower you on your way to better health.
If you follow us on FB or Twitter, that’s great — we really appreciate it. But the fact is, you’re missing important stories — stories that we worked hard to research and write for you. We know from our stats that FB followers see only 1 in 4 stories, on average, and Twitterers even fewer. You might not see something vitally important to you — a drug that you could try, or a side-effect you didn’t know about. We don’t want that to happen.
Instead, sign up for the Crohnology newsletter and never miss a story. It’s free, and you don’t have to be a Crohnology member (although check it out, if you aren’t already). We won’t fill your inbox with spam, and you can unsubscribe any time. Sometimes, we’ll include ads from partners or sponsors — but no snake oil or miracle cures.
The Crohnology newslette: it might save your life. But it probably won’t save your life. It will definitely, for sure give you the best information we can find on managing IBD.